Tools
Tools
Manno, Daniela, Ayieko, Philip, Ishola, David, Afolabi, Muhammed O., Rogers, Baimba, Baiden, Frank, Serry-Bangura, Alimamy, Bah, Osman M., Köhn, Brian, Swaray, Ibrahim, Owusu-Kyei, Kwabena, Otieno, Godfrey T., Kowuor, Dickens, Tindanbil, Daniel, Smout, Elizabeth, Robinson, Cynthia, Keshinro, Babajide, Foster, Julie, Gallagher, Katherine, Lowe, Brett, Douoguih, Macaya, Leigh, Bailah, Greenwood, Brian and Watson-Jones, Deborah (2022) 'Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone'. Emerging Infectious Diseases, Vol 28, Issue 3, pp. 734-738.
|
Text
4. Manno ea 2022 - 21-1496-combined.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Ebola virus (EBOV) antibodies have been found in populations that have never experienced documented Ebola outbreaks and in persons who reported no history of Ebola virus disease (EVD) (1). The clinical significance of these findings is unknown. We conducted a cross-sectional study in healthy adults and children from a population affected by the 2014–2016 EVD outbreak in Sierra Leone and explored the association of antibody seropositivity and concentration with potential risk factors for EBOV infection.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | NOT_LSTM |
| Subjects: | WC Communicable Diseases > WC 20 Research (General) WC Communicable Diseases > Virus Diseases > General Virus Diseases > WC 500 Virus diseases (General or not elsewhere classified) |
| Faculty: Department: | Clinical Sciences & International Health > International Public Health Department |
| Digital Object Identifer (DOI): | https://doi.org/10.3201/eid2803.211496 |
| Depositing User: | Rachel Dominguez |
| Date Deposited: | 15 Jun 2023 08:20 |
| Last Modified: | 15 Jun 2023 08:20 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/22628 |
Statistics
Actions (login required)
 |
Edit Item |